Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma
Hun Jung Kim, Jeong Hoon Phak, Woo Chul Kim
Radiat Oncol J. 2016;34(4):260-264.   Published online 2016 Jun 17     DOI: https://doi.org/10.3857/roj.2015.01571
Citations to this article as recorded by Crossref logo
Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
Narisa Dewi Maulany Darwis, Takahiro Oike, Nobuteru Kubo, Soehartati A Gondhowiardjo, Tatsuya Ohno
Cancers.2020; 12(8): 2180.     CrossRef
Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial
Andrew M. McDonald, Michael C. Dobelbower, Eddy S. Yang, Grant M. Clark, Rojymon Jacob, Robert Y. Kim, Rex A. Cardan, Richard Popple, Jeffrey W. Nix, Soroush Rais-Bahrami, John B. Fiveash
Advances in Radiation Oncology.2019; 4(1): 90.     CrossRef
Sexual Function in Patients Treated With Stereotactic Radiotherapy For Prostate Cancer: A Systematic Review of the Current Evidence
Mauro Loi, Ruud C. Wortel, Giulio Francolini, Luca Incrocci
The Journal of Sexual Medicine.2019; 16(9): 1409.     CrossRef
Radiothérapie stéréotaxique extracrânienne : quelle machine pour quelle indication ? Stéréotaxie prostatique
A. Lapierre, S. Horn, G. Créhange, C. Enachescu, I. Latorzeff, S. Supiot, P. Sargos, C. Hennequin, O. Chapet
Cancer/Radiothérapie.2019; 23(6-7): 651.     CrossRef
Stereotactic Body Radiotherapy for Primary Prostate Cancer
Gargi Kothari, Andrew Loblaw, Alison C. Tree, Nicholas J. van As, Drew Moghanaki, Simon S. Lo, Piet Ost, Shankar Siva
Technology in Cancer Research & Treatment.2018; 17: 153303381878963.     CrossRef
Impact of interfractional motion on hypofractionated pencil beam scanning proton therapy and VMAT delivery for prostate cancer
Maryam Moteabbed, Alexei Trofimov, Fazal H. Khan, Yi Wang, Gregory C. Sharp, Anthony L. Zietman, Jason A. Efstathiou, Hsiao-Ming Lu
Medical Physics.2018; 45(9): 4011.     CrossRef
Détermination des marges du volume cible anatomoclinique au volume cible prévisionnel pour la radiothérapie du cancer prostatique
F. Ramiandrisoa, L. Duvergé, J. Castelli, T.D. Nguyen, S. Servagi-Vernat, R. de Crevoisier
Cancer/Radiothérapie.2016; 20(6-7): 629.     CrossRef